1. Home
  2. VVOS vs BGLC Comparison

VVOS vs BGLC Comparison

Compare VVOS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.19

Market Cap

15.1M

Sector

Health Care

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$2.62

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VVOS
BGLC
Founded
2016
2017
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.1M
10.1M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
VVOS
BGLC
Price
$1.19
$2.62
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$6.25
N/A
AVG Volume (30 Days)
106.3K
7.2K
Earning Date
03-30-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
80.07
45.78
EPS
N/A
N/A
Revenue
$15,031,000.00
$9,510,646.00
Revenue This Year
$31.42
N/A
Revenue Next Year
$49.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.91
N/A
52 Week Low
$1.19
$0.23
52 Week High
$7.40
$15.19

Technical Indicators

Market Signals
Indicator
VVOS
BGLC
Relative Strength Index (RSI) 34.12 55.10
Support Level N/A $2.12
Resistance Level $1.50 $2.73
Average True Range (ATR) 0.11 0.15
MACD 0.00 0.05
Stochastic Oscillator 4.84 83.35

Price Performance

Historical Comparison
VVOS
BGLC

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: